BARCELONA, SPAIN: RF Micro Devices Inc. has expanded its industry-leading 3G front end product portfolio with the RF7234, RFMD's second-generation TD-SCDMA power amplifier (PA).
The dual-mode RF7234 (TD-SCDMA and WCDMA band 1) follows RFMD's first-generation TD-SCDMA PA, the RF3266, which has secured multiple design wins across leading TD-SCDMA reference designs and is forecast to support multiple top-tier handset manufacturers headquartered in Asia and Europe.
Both the RF7234 and RF3266 deliver superior performance at peak power conditions and ample margin across spectral emissions mask requirements – meeting or exceeding the critical performance metrics of today's TD-SCDMA handsets.
Accordingly, RFMD is supporting multiple TD-SCDMA reference designs, including MediaTek and T3G, and RFMD expects robust growth in TD-SCDMA handsets in calendar 2010, driven by Samsung, ZTE, BYD, LG and other leading handset manufacturers.
Eric Creviston, president of RFMD's Cellular Products Group (CPG), said: "RFMD is introducing a record number of new cellular components this year in support of our customers' new handset builds. We are particularly focused on expanding our leadership in 3G with a broad product family that is cost- and feature set-optimized for this rapidly emerging, high-growth category. In TD-SCDMA, we are forecasting strong customer adoption of our RF3266 and RF7234, and we expect robust growth in TD-SCDMA devices in calendar 2010."
The RF7234 and RF3266 expand an industry-leading 3G product portfolio that accommodates all major RF architectures, including existing mode-specific/band-specific and mode-specific/multi-band architectures as well as emerging multimode/multi-band, converged architectures. RFMD's innovative 3G products also include a broad range of GSM/GPRS and EDGE power amplifier-based and switch-based components optimized for 3G mobile internet devices, providing a comprehensive RF product portfolio covering the entire cellular front end.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.